Distinct plasma metabolomic signatures differentiate autoimmune encephalitis from drug‐resistant epilepsy
Annals of Clinical and Translational Neurology · 2024
DOI: 10.1002/acn3.52112 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, 2024. Verfasst von Wenzheng Xiong und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Oxford, Oxford, UK. Hauptthemen laut MEDLINE: Drug Resistant Epilepsy, Encephalitis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, National Medical Research Council, the Fulbright UK-US Commission.
Abstract (Originalsprache)
Objective
Differentiating forms of autoimmune encephalitis (AE) from other causes of seizures helps expedite immunotherapies in AE patients and informs studies regarding their contrasting pathophysiology. We aimed to investigate whether and how Nuclear Magnetic Resonance (NMR)‐based metabolomics could differentiate AE from drug‐resistant epilepsy (DRE), and stratify AE subtypes.
Methods
This study recruited 238 patients: 162 with DRE and 76 AE, including 27 with contactin‐associated protein‐like 2 (CASPR2), 29 with leucine‐rich glioma inactivated 1 (LGI1) and 20 with N‐methyl‐ d ‐aspartate receptor (NMDAR) antibodies. Plasma samples across the groups were analyzed using NMR spectroscopy and compared with multivariate statistical techniques, such as orthogonal partial least squares discriminant analysis (OPLS‐DA).
Results
The OPLS‐DA model successfully distinguished AE from DRE patients with a high predictive accuracy of 87.0 ± 3.1% (87.9 ± 3.4% sensitivity and 86.3 ± 3.6% specificity). Further, pairwise OPLS‐DA models were able to stratify the three AE subtypes. Plasma metabolomic signatures of AE included decreased high‐density lipoprotein (HDL, −(C H 2 ) n −, –C H 3 ), phosphatidylcholine and albumin (lysyl moiety). AE subtype‐specific metabolomic signatures were also observed, with increased lactate in CASPR2, increased lactate, glucose, and decreased unsaturated fatty acids (UFA, –C H 2 CH=) in LGI1, and increased glycoprotein A (GlycA) in NMDAR‐antibody patients.
Interpretation
This study presents the first non‐antibody‐based biomarker for differentiating DRE, AE and AE subtypes. These metabolomics signatures underscore the potential relevance of lipid metabolism and glucose regulation in these neurological disorders, offering a promising adjunct to facilitate the diagnosis and therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Oxford, Oxford, UK.
- Department of Pharmacology, Medical Sciences Division, University of Oxford, Oxford, UK.
- Department of Neurology, National Neuroscience Institute, Singapore, Singapore.
- Duke-NUS Medical School, Singapore, Singapore.
- Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
- Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
ORCID-Profile: Wenzheng Xiong, Sarosh R Irani
Förderung
- Medical Research Council
- National Medical Research Council
- the Fulbright UK-US Commission
- Irish Clinical Academic Training Programme
- British Medical Association
- Epilepsy Research UK
- UCB Pharma
- Wellcome Trust Fellowship
Zitieren
APA
Xiong, W., Yeo, T., May, J. T. M., Demmers, T., Ceronie, B., Ramesh, A., McGinty, R. N., Michael, S., Torzillo, E., Sen, A., Anthony, D. C., Irani, S. R., & Probert, F. (2024). Distinct plasma metabolomic signatures differentiate autoimmune encephalitis from drug‐resistant epilepsy. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.52112
Vancouver
Xiong W, Yeo T, May JTM, Demmers T, Ceronie B, Ramesh A, et al. Distinct plasma metabolomic signatures differentiate autoimmune encephalitis from drug‐resistant epilepsy. Annals of Clinical and Translational Neurology. 2024. doi:10.1002/acn3.52112
BibTeX
@article{Xiong2024,
author = {Xiong, Wenzheng and Yeo, Tianrong and May, Jeanne Tan May and Demmers, Tor and Ceronie, Bryan and Ramesh, Archana and McGinty, Ronan N and Michael, Sophia and Torzillo, Emma and Sen, Arjune and Anthony, Daniel C and Irani, Sarosh R and Probert, Fay},
title = {Distinct plasma metabolomic signatures differentiate autoimmune encephalitis from drug‐resistant epilepsy},
journal = {Annals of Clinical and Translational Neurology},
year = {2024},
doi = {10.1002/acn3.52112}
}
EUVIMED